Clinical Trial Update: Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen

View source ↗

Summary

A single-center, open-label follow-up study of subjects who previously received a rabies vaccine as part of a simulated post-exposure regimen was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies Vaccine (simulated post-exposure regimen) (rabies vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Rabies | Status: TERMINATED